Showing results (241-250 of 382) with videos related to

Sort By:
Pageof 39
BMC Cancer|April 3, 2022
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancerNathanael Raschzok, Sebastian Stintzing, Volker Heinemann, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study groupVerena I Gaidzik, Lars Bullinger, Richard F Schlenk, et al.
Neurosurgery|October 31, 2015
Low-grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance ImagingJan Coburger, Andreas Merkel, Moritz Scherer, et al.
Leukemia|October 3, 2018
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional careHartmut Döhner, Anna Dolnik, Lin Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2025
Spatial tumor immune microenvironment as a prognostic and predictive biomarker in anti-EGFR-based maintenance for RAS wt metastatic CRC - the PanaMa (AIO KRK0212) trialAlexej Ballhausen, Susanna Swoboda, David Horst, et al.
Cytotherapy|November 12, 2024
Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disordersDimitrios Mougiakakos, Ranjita Sengupta, Ralf Gold, et al.
European Journal of Heart Failure|November 27, 2024
New cardiovascular biomarkers in patients with advanced cancer - A prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNPMarkus S Anker, Laura C Lück, Muhammad Shahzeb Khan, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCLKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Blood|December 24, 2010
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityErdogan Taskesen, Lars Bullinger, Andrea Corbacioglu, et al.
Pageof 39